Board of Suven Pharmaceuticals approves investment in a renewable entity
At meeting held on 30 May 2024
The Board of Suven Pharmaceuticals at its meeting held on 30 May 2024 has approved the proposed equity investment of 26% in the SPV (under incorporation) to be engaged in solar power generation for the purpose of captive consumption of the company's plant operations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: May 31 2024 | 10:47 AM IST